Brock Lesnar shown to have failed secondary drug test at UFC 200

In the latest development of his doping scandal, the UFC announced the heavyweight fighter failed a secondary drug test — this time an in-competition test at UFC 200.

The promotion released a statement late on Tuesday (AEST), acknowledging Lesnar had tested positive on July 9 for the same substance that saw him fail an initial test conducted on June 28. 

“The UFC organisation was notified today that the US Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016,” the statement said.

The organisation also noted that despite a secondary test proving positive, and thus making Lesnar’s innocence less likely, the former WWE superstar would still be afforded the same legal review as any other athlete before any penalties were imposed.

“It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.”

The drug Lesnar tested positive to is yet to be publically announced, and will allegedly only be revealed if the fighter himself chooses to announce it.

However speculation has already started as to what the substance may be, with LA Times reporter Lance Pugmire claiming Lesnar was found to have used the same substance that saw interim UFC light heavyweight champion Jon Jones fail a test prior to the massive card.

I'm told by an official with knowledge of Brock Lesnar's positive test that the substance is clomiphene, the same one found in @JonnyBones.

— Lance Pugmire (@latimespugmire) July 19, 2016